Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Sleep Disorders Center of Georgia
mi
from
Atlanta, GA
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Sleep Disorders Center of Georgia
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Neurotrials Research, Inc.
mi
from
Atlanta, GA
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Neurotrials Research, Inc.
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
SleepMed of Central Georgia
mi
from
Macon, GA
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
SleepMed of Central Georgia
mi
from
Macon, GA
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Chicago Research Center, Inc
mi
from
Chicago, IL
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Chicago Research Center, Inc
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
MidAmerica Neuroscience Research Foundation
mi
from
Lenexa, KA
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
MidAmerica Neuroscience Research Foundation
mi
from
Lenexa, KA
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Community Research
mi
from
Crestview Hills, KY
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Community Research
mi
from
Crestview Hills, KY
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Kentucky Research Group
mi
from
Louisville, KY
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Kentucky Research Group
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
The Center for Sleep and Wake Disorders
mi
from
Chevy Chase, MD
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
The Center for Sleep and Wake Disorders
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Pulmonary Disease and Critical Care Associates, P.A.
mi
from
Columbia, MD
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Pulmonary Disease and Critical Care Associates, P.A.
mi
from
Columbia, MD
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Pulmonary and Critical Care Associates of Baltimore
mi
from
Owings Mills, MD
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Pulmonary and Critical Care Associates of Baltimore
mi
from
Owings Mills, MD
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Neurocare, Inc.
mi
from
Newton, MA
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Neurocare, Inc.
mi
from
Newton, MA
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Mid-Michigan Sleep Center
mi
from
Grand Blanc, MI
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Mid-Michigan Sleep Center
mi
from
Grand Blanc, MI
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Minnesota Lung Center and Sleep Institute
mi
from
Edina, MN
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Minnesota Lung Center and Sleep Institute
mi
from
Edina, MN
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Washington University
mi
from
St. Louis, MO
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Wake Research Associates
mi
from
Meredith, NC
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Wake Research Associates
mi
from
Meredith, NC
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Rex Sleep Disorders Center
mi
from
Raleigh, NC
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Rex Sleep Disorders Center
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Ohio Sleep Medicine Institute
mi
from
Dublin, OH
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Ohio Sleep Medicine Institute
mi
from
Dublin, OH
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Mercy St. Vincent Medical Center
mi
from
Toledo, OH
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Mercy St. Vincent Medical Center
mi
from
Toledo, OH
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Center for Sleep Medicine
mi
from
Lafayette Hill, PA
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Center for Sleep Medicine
mi
from
Lafayette Hill, PA
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
SleepMed of South Carolina
mi
from
Columbia, SC
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
SleepMed of South Carolina
mi
from
Columbia, SC
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Future Search Trials of Neurology
mi
from
Austin, TX
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Future Search Trials of Neurology
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Sleep Medicine Associates of Texas
mi
from
Dallas, TX
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Sleep Medicine Associates of Texas
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Todd J. Swick, MD, PA
mi
from
Houston, TX
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Todd J. Swick, MD, PA
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Metroplex Pulmonary and Sleep Center
mi
from
McKinney, TX
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Metroplex Pulmonary and Sleep Center
mi
from
McKinney, TX
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Sleep Therapy and Research Center
mi
from
San Antonio, TX
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Sleep Therapy and Research Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
N-acetylcysteine in Bulimia Nervosa
Status: Enrolling
Updated:  5/8/2013
Lindner Center of HOPE
mi
from
Mason, OH
N-acetylcysteine in Bulimia Nervosa
Status: Enrolling
Updated: 5/8/2013
Lindner Center of HOPE
mi
from
Mason, OH
Click here to add this to my saved trials
Add-On Ramelteon in Bipolar I Disorder With Clinically Significant Sleep Disturbance
A Randomized, Double-Blind, Placebo-Controlled Study of Add-On Ramelteon in Ambulatory Bipolar I Disorder With Clinically Significant Sleep Disturbance
Status: Enrolling
Updated:  5/8/2013
Lindner Center of HOPE
mi
from
Mason, OH
Add-On Ramelteon in Bipolar I Disorder With Clinically Significant Sleep Disturbance
A Randomized, Double-Blind, Placebo-Controlled Study of Add-On Ramelteon in Ambulatory Bipolar I Disorder With Clinically Significant Sleep Disturbance
Status: Enrolling
Updated: 5/8/2013
Lindner Center of HOPE
mi
from
Mason, OH
Click here to add this to my saved trials
Interventions for Communication in Autism Network
Multisite Randomized Control Treatment of Early Intervention for Spoken Communication in Autism
Status: Enrolling
Updated:  5/13/2013
University of California at Los Angeles
mi
from
Los Angeles, CA
Interventions for Communication in Autism Network
Multisite Randomized Control Treatment of Early Intervention for Spoken Communication in Autism
Status: Enrolling
Updated: 5/13/2013
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Interventions for Communication in Autism Network
Multisite Randomized Control Treatment of Early Intervention for Spoken Communication in Autism
Status: Enrolling
Updated:  5/13/2013
Kennedy Krieger Institute
mi
from
Baltimore, MD
Interventions for Communication in Autism Network
Multisite Randomized Control Treatment of Early Intervention for Spoken Communication in Autism
Status: Enrolling
Updated: 5/13/2013
Kennedy Krieger Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Interventions for Communication in Autism Network
Multisite Randomized Control Treatment of Early Intervention for Spoken Communication in Autism
Status: Enrolling
Updated:  5/13/2013
University of Rochester
mi
from
Rochester, NY
Interventions for Communication in Autism Network
Multisite Randomized Control Treatment of Early Intervention for Spoken Communication in Autism
Status: Enrolling
Updated: 5/13/2013
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety
A Phase 1-b Non-blinded Study of Safety, Tolerability and Efficacy of Lorexys in Premenopausal Women With Hypoactive Sexual Desire Disorder
Status: Enrolling
Updated:  5/15/2013
Robert Taylor Segraves, MD, PhD
mi
from
Beachwood, OH
Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety
A Phase 1-b Non-blinded Study of Safety, Tolerability and Efficacy of Lorexys in Premenopausal Women With Hypoactive Sexual Desire Disorder
Status: Enrolling
Updated: 5/15/2013
Robert Taylor Segraves, MD, PhD
mi
from
Beachwood, OH
Click here to add this to my saved trials
Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety
A Phase 1-b Non-blinded Study of Safety, Tolerability and Efficacy of Lorexys in Premenopausal Women With Hypoactive Sexual Desire Disorder
Status: Enrolling
Updated:  5/15/2013
Molly Katz, MD
mi
from
Cincinnati, OH
Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety
A Phase 1-b Non-blinded Study of Safety, Tolerability and Efficacy of Lorexys in Premenopausal Women With Hypoactive Sexual Desire Disorder
Status: Enrolling
Updated: 5/15/2013
Molly Katz, MD
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Neurochemical Effects of Omega-3 Fatty Acids in Adolescents at Risk for Mania
Neurochemical Effects of Omega-3 Fatty Acids in Adolescents at Risk for Mania
Status: Enrolling
Updated:  5/16/2013
University of Cincinnati
mi
from
Cincinnati, OH
Neurochemical Effects of Omega-3 Fatty Acids in Adolescents at Risk for Mania
Neurochemical Effects of Omega-3 Fatty Acids in Adolescents at Risk for Mania
Status: Enrolling
Updated: 5/16/2013
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Examining a Common Complaint of Women Who Receive Chemotherapy for Breast Cancer- Cognitive Difficulty
Neurocognitive Impairment in Women With Early Stage Breast Cancer
Status: Enrolling
Updated:  5/16/2013
Virnigia Commonwealth University
mi
from
Richmond, VA
Examining a Common Complaint of Women Who Receive Chemotherapy for Breast Cancer- Cognitive Difficulty
Neurocognitive Impairment in Women With Early Stage Breast Cancer
Status: Enrolling
Updated: 5/16/2013
Virnigia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Prevention of Delirium After Bone Marrow Transplantation
Usefulness of Bright Light Therapy in the Prevention of Delirium in Patients Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Status: Enrolling
Updated:  5/16/2013
Massachusetts General Hospital
mi
from
Boston, MA
Prevention of Delirium After Bone Marrow Transplantation
Usefulness of Bright Light Therapy in the Prevention of Delirium in Patients Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Status: Enrolling
Updated: 5/16/2013
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana
Laboratory Study of the Influence of Oral Cannabidiol on the Subjective, Reinforcing and Cardiovascular Effects of Smoked Marijuana
Status: Enrolling
Updated:  5/21/2013
University of Kentucky, Straus Behavioral Research Bldg., 515 Oldham Ct.
mi
from
Lexington, KY
Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana
Laboratory Study of the Influence of Oral Cannabidiol on the Subjective, Reinforcing and Cardiovascular Effects of Smoked Marijuana
Status: Enrolling
Updated: 5/21/2013
University of Kentucky, Straus Behavioral Research Bldg., 515 Oldham Ct.
mi
from
Lexington, KY
Click here to add this to my saved trials
Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana
Laboratory Study of the Influence of Oral Cannabidiol on the Subjective, Reinforcing and Cardiovascular Effects of Smoked Marijuana
Status: Enrolling
Updated:  5/21/2013
Marijuana Outpatient Lab 1051 Riverside Dr. Unit #120
mi
from
New York, NY
Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana
Laboratory Study of the Influence of Oral Cannabidiol on the Subjective, Reinforcing and Cardiovascular Effects of Smoked Marijuana
Status: Enrolling
Updated: 5/21/2013
Marijuana Outpatient Lab 1051 Riverside Dr. Unit #120
mi
from
New York, NY
Click here to add this to my saved trials
Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana
Laboratory Study of the Influence of Oral Cannabidiol on the Subjective, Reinforcing and Cardiovascular Effects of Smoked Marijuana
Status: Enrolling
Updated:  5/21/2013
Center for Drug and Alcohol Programs, Room 459 North, 67 President St.
mi
from
Charleston, SC
Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana
Laboratory Study of the Influence of Oral Cannabidiol on the Subjective, Reinforcing and Cardiovascular Effects of Smoked Marijuana
Status: Enrolling
Updated: 5/21/2013
Center for Drug and Alcohol Programs, Room 459 North, 67 President St.
mi
from
Charleston, SC
Click here to add this to my saved trials
Neuroimaging of Diet in ADHD: Phase I
Neuroimaging of Diet and Medication in the Treatment of ADHD
Status: Enrolling
Updated:  5/21/2013
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Neuroimaging of Diet in ADHD: Phase I
Neuroimaging of Diet and Medication in the Treatment of ADHD
Status: Enrolling
Updated: 5/21/2013
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Trial of Methyl B12 on Behavioral and Metabolic Measures in Children With Autism
Double Blind Placebo Controlled Trial of Methyl B12 on Behavioral and Metabolic Measures in Children With Autism
Status: Enrolling
Updated:  5/22/2013
University of California at San Francisco (UCSF)
mi
from
San Francisco, CA
Trial of Methyl B12 on Behavioral and Metabolic Measures in Children With Autism
Double Blind Placebo Controlled Trial of Methyl B12 on Behavioral and Metabolic Measures in Children With Autism
Status: Enrolling
Updated: 5/22/2013
University of California at San Francisco (UCSF)
mi
from
San Francisco, CA
Click here to add this to my saved trials
Cranial Electrotherapy Stimulation (CES) to Treat PTSD
Cranial Electrotherapy Stimulation (CES) to Treat PTSD: Identifying Metrics of Efficacy Using Brain Imaging
Status: Enrolling
Updated:  5/22/2013
McLean Hospital
mi
from
Belmont, MA
Cranial Electrotherapy Stimulation (CES) to Treat PTSD
Cranial Electrotherapy Stimulation (CES) to Treat PTSD: Identifying Metrics of Efficacy Using Brain Imaging
Status: Enrolling
Updated: 5/22/2013
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
Cognitive Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder
Cognitive-Behavioral Therapy & Glutamatergic Neurometabolites in Pediatric OCD
Status: Enrolling
Updated:  5/24/2013
UCLA Child Psychiatry
mi
from
Los Angeles, CA
Cognitive Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder
Cognitive-Behavioral Therapy & Glutamatergic Neurometabolites in Pediatric OCD
Status: Enrolling
Updated: 5/24/2013
UCLA Child Psychiatry
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Bupropion for ADHD in Adolescents With Substance Use Disorder
Bupropion for ADHD in Adolescents With Substance Use Disorder
Status: Enrolling
Updated:  5/28/2013
University of Colorado Denver, Adolescent Clinical Research
mi
from
Denver, CO
Bupropion for ADHD in Adolescents With Substance Use Disorder
Bupropion for ADHD in Adolescents With Substance Use Disorder
Status: Enrolling
Updated: 5/28/2013
University of Colorado Denver, Adolescent Clinical Research
mi
from
Denver, CO
Click here to add this to my saved trials
Computer Assisted Cognitive Behavior Therapy for Obsessive Compulsive Disorder: A Comprehensive Stepped-Care Approach
Computer Assisted CBT for OCD: A Comprehensive Stepped-Care Approach
Status: Enrolling
Updated:  5/29/2013
Center for Psychological Consultation
mi
from
Madison, WI
Computer Assisted Cognitive Behavior Therapy for Obsessive Compulsive Disorder: A Comprehensive Stepped-Care Approach
Computer Assisted CBT for OCD: A Comprehensive Stepped-Care Approach
Status: Enrolling
Updated: 5/29/2013
Center for Psychological Consultation
mi
from
Madison, WI
Click here to add this to my saved trials
Participant Database for Autism Research Studies
Participant Database for Persons Interested in Autism Research Studies: Recruiting, Pre-Screening and Diagnostic Assessment
Status: Enrolling
Updated:  5/31/2013
Martinos Center for Biomedical Imaging
mi
from
Charlestown, MA
Participant Database for Autism Research Studies
Participant Database for Persons Interested in Autism Research Studies: Recruiting, Pre-Screening and Diagnostic Assessment
Status: Enrolling
Updated: 5/31/2013
Martinos Center for Biomedical Imaging
mi
from
Charlestown, MA
Click here to add this to my saved trials
Cognitive Behavioral Therapy (CBT) for Posttraumatic Stress Disorder (PTSD) in Community Addiction Treatment
A Stage II Efficacy Study of Cognitive Behavioral Therapy for PTSD in Community Addiction Treatment
Status: Enrolling
Updated:  6/10/2013
Central Vermont Substance Abuse Services
mi
from
Berlin, VT
Cognitive Behavioral Therapy (CBT) for Posttraumatic Stress Disorder (PTSD) in Community Addiction Treatment
A Stage II Efficacy Study of Cognitive Behavioral Therapy for PTSD in Community Addiction Treatment
Status: Enrolling
Updated: 6/10/2013
Central Vermont Substance Abuse Services
mi
from
Berlin, VT
Click here to add this to my saved trials
Cognitive Behavioral Therapy (CBT) for Posttraumatic Stress Disorder (PTSD) in Community Addiction Treatment
A Stage II Efficacy Study of Cognitive Behavioral Therapy for PTSD in Community Addiction Treatment
Status: Enrolling
Updated:  6/10/2013
Brattleboro Retreat
mi
from
Brattleboro, VT
Cognitive Behavioral Therapy (CBT) for Posttraumatic Stress Disorder (PTSD) in Community Addiction Treatment
A Stage II Efficacy Study of Cognitive Behavioral Therapy for PTSD in Community Addiction Treatment
Status: Enrolling
Updated: 6/10/2013
Brattleboro Retreat
mi
from
Brattleboro, VT
Click here to add this to my saved trials
Cognitive Behavioral Therapy (CBT) for Posttraumatic Stress Disorder (PTSD) in Community Addiction Treatment
A Stage II Efficacy Study of Cognitive Behavioral Therapy for PTSD in Community Addiction Treatment
Status: Enrolling
Updated:  6/10/2013
Howard Center
mi
from
Burlington, VT
Cognitive Behavioral Therapy (CBT) for Posttraumatic Stress Disorder (PTSD) in Community Addiction Treatment
A Stage II Efficacy Study of Cognitive Behavioral Therapy for PTSD in Community Addiction Treatment
Status: Enrolling
Updated: 6/10/2013
Howard Center
mi
from
Burlington, VT
Click here to add this to my saved trials
Cognitive Behavioral Therapy (CBT) for Posttraumatic Stress Disorder (PTSD) in Community Addiction Treatment
A Stage II Efficacy Study of Cognitive Behavioral Therapy for PTSD in Community Addiction Treatment
Status: Enrolling
Updated:  6/10/2013
Evergreen - Rutland Mental Health
mi
from
Rutland, VT
Cognitive Behavioral Therapy (CBT) for Posttraumatic Stress Disorder (PTSD) in Community Addiction Treatment
A Stage II Efficacy Study of Cognitive Behavioral Therapy for PTSD in Community Addiction Treatment
Status: Enrolling
Updated: 6/10/2013
Evergreen - Rutland Mental Health
mi
from
Rutland, VT
Click here to add this to my saved trials
Burden, Belonging, and Response to Pain in Veterans
Burden, Belonging, and Response to Pain in Veterans
Status: Enrolling
Updated:  6/12/2013
Va Visn 19 Mirecc
mi
from
Denver, CO
Burden, Belonging, and Response to Pain in Veterans
Burden, Belonging, and Response to Pain in Veterans
Status: Enrolling
Updated: 6/12/2013
Va Visn 19 Mirecc
mi
from
Denver, CO
Click here to add this to my saved trials